These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 20077334)

  • 1. Avoiding over-deterrence in managing physicians' relationships with industry.
    Stell LK
    Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug detailers, professionalism, and prudence.
    Brody H
    Am J Bioeth; 2010 Jan; 10(1):9-10. PubMed ID: 20077325
    [No Abstract]   [Full Text] [Related]  

  • 3. The devil in the detail(ing).
    Morreim H
    Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328
    [No Abstract]   [Full Text] [Related]  

  • 4. Contact with pharmaceutical representatives: where does prudence lead?
    Appelbaum PS
    Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326
    [No Abstract]   [Full Text] [Related]  

  • 5. Why academic medical centers should ban drug company gifts to individuals.
    Strong C
    Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327
    [No Abstract]   [Full Text] [Related]  

  • 6. The AAMC exhibits the behavior it condemns.
    Stossel TP
    Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333
    [No Abstract]   [Full Text] [Related]  

  • 7. The pitfalls of misreading: what does "industry funding of medical education" actually say?
    Spielman B
    Am J Bioeth; 2010 Jan; 10(1):24-5. PubMed ID: 20077332
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
    Huddle TS
    Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
    [No Abstract]   [Full Text] [Related]  

  • 9. The details are in the field.
    Schwab AP
    Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330
    [No Abstract]   [Full Text] [Related]  

  • 10. Huddle gets it right, most docs don't.
    Rubin PH
    Am J Bioeth; 2010 Jan; 10(1):17-9. PubMed ID: 20077329
    [No Abstract]   [Full Text] [Related]  

  • 11. The pitfalls of deducing ethics from behavioral economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing.
    Huddle TS
    Am J Bioeth; 2010 Jan; 10(1):1-8. PubMed ID: 20077321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
    Steinman MA; Schillinger D
    Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
    [No Abstract]   [Full Text] [Related]  

  • 13. Doctors and the drug industry: reader feedback.
    Warrier R; Houghton B
    Am J Med; 2005 Oct; 118(10):1175-6; author reply 1176. PubMed ID: 16194656
    [No Abstract]   [Full Text] [Related]  

  • 14. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
    Mehta RS
    Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
    [No Abstract]   [Full Text] [Related]  

  • 15. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Banning pens and pads misses the main point.
    Terry SF; Burke W
    Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
    [No Abstract]   [Full Text] [Related]  

  • 17. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug industry is told to stop gifts to doctors.
    Pear R
    N Y Times Web; 2002 Oct; ():A1, A29. PubMed ID: 12474836
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicine and the pharmaceutical industry: a call to action.
    Stiles MM; Barrett B
    Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increase in incidence of drug treatments, ethical principles and conflict of interest in cooperation with the pharmaceutical industry].
    Hebebrand J; Blanz B; Herpertz-Dahlmann B; Lehmkuhl G
    Z Kinder Jugendpsychiatr Psychother; 2012 May; 40(3):133-8. PubMed ID: 22774235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.